China’s 13th National People’s Congress approved a merger of a host of current regulatory agencies – including CFDA, into a new super-ministry for all things regulatory. We take a look at the powers of the new SMRA – or the State Market Regulatory Administration and ask what it means for CFDA’s devices reforms.
At the March 2018 Shanghai meeting of IMDRF, new work item proposals from China on GCP practices and the update of technical standards were approved. These seemingly routine administrative efforts mask a radical change – with China for the first time taking the lead on IMDRF harmonization efforts and seeking to promulgate its own approaches into global regulation. We take a look at what’s really going on.
TGA is proceeding to update its Advertising regulations. The next step is a public consultation ending 27 April 2018. We look at the specific changes and their impact.
Over the past few months, I’ve had numerous conversations with US Manufacturers, Regulators and others about CFDA’s Innovative Device Pathway. And it’s clear there’s a real misunderstanding about the actual benefits and challenges this Pathway brings. In this article, I try to make it a little clearer on what leads to a successful application and… Learn more
Even though the February 2018 Prostheses List has yet to come into effect, the deadlines for submitting applications to the August List are fast approaching. Missing a deadline can delay your access to the private hospital market by at least 6 months. The deadline for Ophthalmic, Urogenital, Specialist Orthopaedic, Cardiac, Cardiothoracic, Vascular, Hip, Knee and… Learn more
Don't miss out, watch now...
Join us on March 19-20, 2018 in Yorba Linda, California for an exceptional event that will bring you face-to-face with local experts from India to Japan, China to Australia and more. Discover what it takes to succeed in APAC markets. Can’t make it to California in March? This is so good we are running it twice – also on February 1-2, 2018 in Zurich, Switzerland
Latest Events and Webinars
Serving the industry for close to 20 years, we bring a track record and credibility that is second to none. Choose a regulatory partner that combines deep expertise with a flexible, strategic approach and a commercial focus that never loses sight of your objective - market access.
Risk Assessments, Design Controls, Biocompatibility , Clinical Evaluation Reports we can provide comprehensive technical support to ensure compliant product development. We can prepare full regulatory submissions for Medical Devices (including medical software) IVDs and combination products. We have the depth of technical expertise and international experience you need to support your expanding business.
Product recall? Warning Letter? Audit failure? Cancellation of Registration? Don’t Panic! We are experienced in dealing directly with regulators to resolve postmarket issues smoothly and with minimum fuss.
A quality culture adds real value to your business and ensures compliance runs smoothly. Let us help you – with individual processes, independent internal audit support or building a complete system. We are experienced in ISO 13485 and 21CFR 820 (QSR) for design and manufacturer and in ISO 17025 and 21CFR 58 for laboratories.